Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 143

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 143
---
 the Termination Date will automatically be extended to September 30, 2025, and (2) the right to terminate the Divestiture Agreement pursuant to this provision will not be available to either          
 Kaken or Aadi if the other party has the right to terminate the Divestiture Agreement pursuant to certain termination provisions of the Divestiture Agreement, or such party’s action or failure to act (which action or failure to act constitutes      
 a breach by such party of the Divestiture Agreement) has been the primary cause of, or primarily resulted in the failure of the completion of the Divestiture to have occurred prior to the Termination Date, including by resulting in a failure of any 
 condition to the Divestiture set forth in the Divestiture Agreement; or                                                                                                                                                                                  |

| • |     | Aadi stockholders do not approve the Divestiture Agreement and the Divestiture at the Special Meeting, except                                                                                                                                      
 that a party may not terminate the Divestiture Agreement pursuant to this provision if such party’s action or failure to act (which action or failure to act constitutes a breach by such party of the Divestiture Agreement) has been the primary 
 cause of, or primarily resulted in, the failure to obtain the approval of Aadi stockholders at the Special Meeting;                                                                                                                                |

| • |     | by Kaken if: |

| • |     | subject to a 20-day cure period, Aadi has breached or failed to perform                                                    
 in any material respect any of its representations, warranties, covenants or other agreements contained in the Divestiture |

- 92 -

| Agreement such that the related closing condition would not be satisfied, unless Kaken is in breach in any material respect of any of its representations, warranties, covenants or other 
 agreements contained in the Divestiture Agreement; or                                                                                                                                     |

| • |     | prior to the approval of the Divestiture Agreement and the Divestiture by Aadi stockholders, Aadi’s board of 
 directors has effected an Aadi Board Recommendation Change; and                                              |

| • |     | by Aadi if: |

| • |     | subject to a 20-day cure period, Kaken has breached or failed to perform                                                                                                                                                                                 
 in any material respect any of its representations, warranties, covenants or other agreements contained in the Divestiture Agreement such that the related closing condition would not be satisfied, unless Aadi is in breach in any material respect of 
 any of its representations